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INTRODUCTION
In dermatology, topical therapies are usually the first line 
and mainstay of treatment for the majority of skin condi-
tions. Most topical preparations are available in a variety of 
potencies and delivery systems. Practitioners must carefully 
choose from this vast array based on the potency required, 
location of intended use, product elegance, and likelihood 
of patient compliance. Unfortunately, information concern-
ing which preparation is truly best, regarding actual penetra-
tion and delivery to the site of action, is not readily available. 
In general, many practitioners believe that ointments and 
foams enhance penetration when compared to creams, gels, 
and powders. However, this is not always the case. Aside 
from vehicles, there are a variety of chemical and physical 
enhancement techniques that influence topical penetration. 
As physician-scientists, dermatologists should be aware of 
the basic mechanisms involved in topical absorption and 
should be able to assess whether a preparation is likely to 
exert its desired effect. In this article, we explore the inherent 
properties of the epidermis and the physiology of passive dif-
fusion and aim to clarify the definition of the terms “absorp-
tion” and “penetration.”
ACCUMULATION VERSUS PENETRATION
The terms “absorption,” which is the accumulation of drug in 
the skin, and “penetration,” which is a measure of flux/trans-
port across the skin, are often incorrectly used interchange-
ably. Penetration is quantifiable as the amount of substance 
that crosses the skin per unit area per unit time. By con-
trast, “absorption,” or “accumulation,” refers to the amount 
of a substance that builds up in the skin over a certain time 
period. The accumulated substance may remain in the skin 
or leave the skin to enter the systemic circulation. Whether 
the substance exerts a biological effect, is inert, is metabo-
lized (and at what rate), and/or is soluble can impact the sub-
stance’s concentration in the skin at any given time, making 
the results difficult to compare and reproduce. 
There are two general routes through which topically 
applied preparations can enter the skin: transepidermal (via 
the stratum corneum) and transappendageal (via appendages 
such as eccrine ducts and hair follicles). Transepidermal pen-
• The terms “absorption” and “penetration” are 
often used interchangeably, which is incorrect.
• “Absorption,” or “accumulation,” refers to the 
amount of substance that builds up in the 
skin over a certain period of time whereas 
“penetration” is the amount of a substance that 
crosses the skin per unit area per unit time. 
• The stratum corneum is the greatest barrier against 
drug penetration.
• The extracellular lipid composition of the 
epidermis plays a large role in barrier function.
• There are numerous techniques, both passive and 
active, to enhance drug penetration through the 
skin. 
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etration can be either transcellular (through the corneocytes 
and the lipid lamella) or intercellular (through a complex 
pathway along the lipid lamella). Generally, it is believed that 
the penetration of topical drugs occurs primarily through the 
intercellular route, given the hydrophobic nature of the extra-
cellular space. Although it has traditionally been thought that 
the transcellular and transappendageal routes contribute only 
slightly to the overall drug transport, the former is important 
for small hydrophobic molecules and the latter may in fact be 
underestimated in certain cases. Transappendageal transport of 
the follicular type has become a focus of research in the past 
decade because hair follicles represent an effective reservoir 
and contain target sites such as stem cells and dendritic cells. 
The reservoir effect of follicles is profound, measuring up to 
10 times larger than that of the surrounding skin (Shah et al., 
2014). However, there are two major issues with the follicu-
lar pathway. The first is the fact that although some substances 
can pass deep into hair follicles, none has been able to pass 
transfollicularly into the surrounding skin or penetrate into the 
circulation. The second is the lack of a proper skin model other 
than intact human skin for researching transport through the 
transfollicular pathway. 
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One approach to solving the penetration problem is the use 
of triggered release mechanisms. This allows the drug to be 
released independently after it has been delivered deep into 
the hair follicle. The drug can then pass through the hair folli-
cle and into the surrounding skin. Currently, a number of these 
release triggers are under investigation and include radiofre-
quency, ultrasound, light, enzymatic reactions, and pH manip-
ulation (Shah et al., 2014).
BARRIER PROPERTIES OF THE SKIN
The stratum corneum of the stratified epidermis functions as 
the single greatest barrier against drug penetration (Bouwstra 
et al., 2001; Jain, 2008). A major component of this barrier 
is extracellular lipids, which are extruded into the extracel-
lular space as cells transition from the granular layer to the 
stratum corneum. In conjunction with this lipid-rich extracel-
lular space, limited desquamation of corneocytes provides a 
homeostatic layer of cells that protects the underlying epider-
mis. Together, this arrangement of corneocytes in the stratum 
corneum and the formation of a lipid-rich extracellular space 
has been coined the “bricks-and-mortar” model (Figure 1) 
(Bolognia et al., 2012; Bouwstra and Ponec, 2006; Lampe et 
al., 1983; Hachem et al., 2003; Elias et al., 2006; Shah et al., 
2014; Jain, 2008).
The lipid-rich, hydrophobic, extracellular space of the 
stratum corneum is predominated by ceramides, choles-
terol, and free fatty acids (Bouwstra and Ponec, 2006; 
Shah et al., 2014). This extracellular space is formed by the 
conversion of lipids extruded from lamellar bodies in the 
stratum granulosum (i.e., glucosylceramides, sphingomy-
elin, cholesterol, and phospholipids). The conversion of 
these precursor lipids into their final end products occurs 
mainly by the following enzymes, which are also extruded 
from lamellar bodies: β-glucocerebrosidase, acid sphingo-
myelinase, secretory phospholipase A2, and proteases. In 
contrast to the extracellular space of the stratum corneum, 
the extracellular space in the layers including and between 
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Figure 1. Basic structure of the stratum corneum. (a) “Bricks-and-mortar” model of the epidermis. The extracellular space of the stratum granulosum and 
stratum corneum exhibits hydrophobic properties due to its lipid-rich composition. This is in contrast to the layers below the stratum granulosum, which exhibit 
a hydrophilic environment due to the lipid-poor, desmosome-rich composition. pH = ~7.3 in stratum granulosum; pH = ~5.0 in the mid–stratum corneum. (b) 
Formation of lipid-rich extracellular space. Expulsion of lamellar bodies and conversion of lipids into final end products.
Figure 2. “Pore” pathway within the stratum corneum. Aqueous pores 
represent discontinuous lacunar domains formed by the degradation of 
corneodesmosomes. Under certain conditions, such as extensive hydration, 
occlusion, and sonophoresis, these pores enlarge, extend, and connect, 
creating a continuous pathway through the stratum corneum. Adapted from 
Bolognia et al. (2012) with permission from Elsevier.
the stratum basale and the stratum granulosum consists of 
a hydrophilic environment predominated by proteinaceous 
molecules such as desmosomes (Elias et al., 1977). Because 
of the importance of the stratum corneum lipids in barrier 
function, it is likely that there are many enhancers/excipi-
Discontinuous,
nonpermeable lacunar system:
basal conditions
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permeable lacunar system
Permeabilization
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ents that affect these lipids in some way. Some substances 
such as DMSO and azone are thought to distort the packing 
geometry of these intercellular lipids. Oleic acid, azone, 
and terpenes have been shown to induce discreet domains 
in the stratum corneum lipids where the excipient is con-
centrated, resulting in barrier defects. Surfactants such as 
sodium lauryl sulfate may work by solubilizing stratum cor-
neum lipids (Williams and Barry, 2004).
Table 1. The effect of various vehicles on the permeability of the stratum corneum
Vehicle Examples Effect Permeability
Occlusive dressings Films, plaster, and transdermal patches Prevents water loss 
Lipophilic vehicle Paraffins, oils, fats, waxes, alcohols, esters, 
silicones
Prevents water loss 
Absorption base Anhydrous lipids ± emulsifiers Prevents water loss 
Emulsifying base Anhydrous lipids ± emulsifiers Prevents water loss 
Water–oil emulsion Oily creams (w/o systems) Retards water loss 
Oil–water emulsion Aqueous creams (w/o systems) May donate water  (?)
Humectant Water-soluble bases, glycerol, glycols Dependent on the concentration  
of the humectant
Dependent on the concentra-
tion  
of the humectant
Powder Clays, shake lotions Aids evaporation no effect/
Adapted from Barry (2001) with permission from Elsevier.
Table 2.  The advantages and disadvantages of excipients
Excipient Advantages Disadvantages Other
DMSO • Effective in both hydrophilic and lipo-
philic permeants
• High concentrations needed for effect; 
high concentrations often cause erythema 
and urticaria
• Produces a metabolite that can produce a 
foul odor on the breath
• Changes keratin confirmation and 
may distort the packing arrangement 
of intercellular lipids
Ethanol • Permeates rapidly through skin • Concerns about systemic toxicity, espe-
cially in the pediatric population
• Mechanism of action may involve 
evaporative loss of ethanol, leaving 
behind the drug in a supersaturated 
state
Pyrrolidones • Can create reservoirs of a drug and 
potentially be used for sustained release of 
a topical drug 
• Works better with hydrophilic substances 
• Can cause erythema and other adverse 
reactions
• Has been used to enhance 
transport of mannitol, 5-fluorouracil, 
β-methasone, hydrocortisone
Fatty acids (oleic acid) • Effective for a wide range of drugs
• Can work with lipophilic and hydro-
philic substances
• Effective at low concentrations
• Only fatty acids of a certain length and 
chain figuration have a significant effect on 
transport
• The cis-configuration disturbs 
lipid packing more and therefore 
has more potential for transport 
enhancement
Urea • Has additional keratolytic properties that 
can be useful in some disease states
• Has only modest transport enhancement 
when used alone as an excipient
• Some studies show that synthetic 
analogues of urea have a greater 
effect on transport
Essential oils • Some reports have shown essential oils 
to have up to a 100-fold increase in per-
meability coefficient of the target drug
• Synergistic effect when combined with 
propylene glycol
• Effects are often drug specific and not 
effective for lipophilic drugs
• Used in medicines, fragrance, and 
flavorings
Phospholipids (nonvesicular) • Can increase tissue hydration • Few studies on phospholipids in the 
nonvesicular form
Azone • Low irritation and low toxicity
• Low pharmacologic activity
• Active at low concentrations
• Enhances transport of a wide variety of 
drugs
• Unknown mechanism of action
• Works better for hydrophilic substances 
than for lipophilic substances
• Thought to disrupt packing ar-
rangement of lipids in lipid bilayers
Adapted from Williams and Barry (2004) with permission from Elsevier.
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It has been reported that the conversion of lipids into their 
final end products is facilitated by acidification of the extra-
cellular space of the stratum granulosum and the stratum cor-
neum. This “acid mantle” is created primarily via two mecha-
nisms (Hachem et al., 2003). The first mechanism involves a 
non–energy dependent sodium–proton exchanger on the sur-
face of upper epidermal keratinocytes, which pumps protons 
extracellularly. The second mechanism involves conversion 
of phospholipids into free fatty acids via phospholipase A2, 
which provides an acidic environment through the inherently 
acidic moieties on the free fatty acids. Together, the sodium–
proton exchanger and free fatty acids create the necessary pH 
for optimal activity of β-glucocerebrosidase and acid sphin-
gomyelinase, which convert precursor sphingolipids into 
ceramides, a very important constituent of the stratum corne-
um (Hachem et al., 2003).
Just as the “acid mantle” facilitates the formation of a 
lipid-rich extracellular space to limit drug penetration, so 
too does it indirectly limit desquamation, further fortifying 
the barrier function of the stratum corneum (Hachem et al., 
2003). Particularly, the low pH of the extracellular space in 
the upper epidermis limits the degradation of corneodesmo-
somes, mostly desmoglein 1, by proteases. In contrast, if the 
pH were higher, protease activity in the extracellular space 
would increase and desquamation would occur at a more 
rapid rate. This further illustrates the importance of pH on the 
barrier function of the skin. 
REGIONAL VARIATION
Epidermal permeability changes depending on body site. 
This knowledge is important when choosing the correct 
potency and vehicle of a topical preparation, both for effica-
cy and for avoiding adverse effects. Although most clinicians 
believe that skin penetration correlates with skin thickness, 
differences in drug penetration can actually be explained 
by variations in the number of lamellar membranes (lipid 
weight %), membrane structure, and/or lipid composition 
(i.e., sphingomyelin:ceramide ratio) (Bolognia et al., 2012).
PHYSIOLOGY OF PASSIVE TRANSPORT AND ENHANCERS
Transport across the stratum corneum is passive. Fick’s law 
(Jain, 2008), a passive diffusion model, can therefore be used 
to calculate skin permeation as follows
where J is the flux/unit area, K is the partition coefficient 
(hydrophilicity), D is diffusity, h is skin thickness, c0 is the 
concentration of the substance applied, and c1 is the con-
centration of the substance in the skin. c1 is often set to 
zero with the assumption that the skin initially contains no 
amount of the substance being studied. Using this model, 
inward flux is positively correlated with the hydrophobicity 
of the topical preparation and the concentration gradient and 
negatively correlated with the penetration pathway length. In 
this respect, with additional factors aside, the highest pen-
etration occurs with a hydrophobic drug applied to a thin 
1. The amount of substance crossing the skin per unit 
area per unit time defines which of the following 
terms?
A. Accumulation. 
B. Penetration. 
C. Absorption.
D. Supersaturation.
2. Which of the following effects is seen with increased 
pH?
A. Increased desquamation. 
B. Decreased desquamation. 
C. Facilitation of sphingomyelinase.
D. Increased barrier function.
3. According to Fick’s equation, which of the following 
will increase flux across the epidermis?
A. High concentration of the substance in the skin 
before application.
B. High partition coefficient. 
C. High skin thickness.
D. Low diffusivity. 
4. Which excipient/enhancer of excipient is thought to 
work by evaporation and subsequent formation of 
the drug in a supersaturated state? 
A. DMSO.
B. Ethanol. 
C. Azone.
D. Urea.
5. The extracellular space of the stratum corneum is 
described as which of the following?
A. Hydrophobic.
B. Hydrophilic.
C. Neutral in polarity.
D. Both hydrophobic and hydrophilic.
QUESTIONS
This article has been approved for 1 hour of Category 1 CME credit. To 
take the quiz, with or without CME credit, follow the link under the “CME 
ACCREDITATION” heading.
For each question, more than one answer may be correct.
stratum corneum and no drug already present in the skin. The 
relationship between flux and concentration gradient can be 
manipulated via supersaturation by increasing c0, the con-
centration of substance applied, in Fick’s equation. 
Although the inherent properties of the stratum corneum 
and drug are important factors in penetration, the hydration 
of the epidermis is an additional factor to consider. Although 
it is not entirely clear by which mechanism water affects skin 
permeability, it is understood that water typically enhances 
KDJ = h
(c0-c1)
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drug penetration. One hypothesis is that water increases 
topical drug delivery by exploiting a network of “aqueous 
pores” (Figure 2). Normally, this network, which consists of 
lacunae at sites of corneodesmosome degradation, is inter-
rupted (Williams and Barry, 2004). However, under certain 
conditions, such as extensive hydration, occlusion, and 
sonophoresis, the lacunae form connections that create a 
pathway through the stratum corneum (Williams and Barry, 
2004; Bolognia et al., 2012). The existence of these pores 
not only adds to the already numerous transepidermal path-
ways but also provides future opportunities for drug delivery 
manipulation (Bolognia et al., 2012). Of particular interest, 
vehicle characteristics (reviewed in Table 1) can be influen-
tial in increasing hydration (Barry, 2001).
Furthermore, the addition of excipients, nonactive addi-
tives, can promote penetration. Some of the most stud-
ied excipients are water, DMSO, azone, N-methyl-2-
pyrrolidone, 2-pyrrolidone, fatty acids, ethanol, propylene 
glycol, urea, menthol, and essential oils. The advantages 
and disadvantages of these excipients are outlined in Table 2 
(Williams and Barry, 2004).
Finally, another mode of enhancement to consider is the 
use of nanoparticles, especially given that their use is the 
most active direction of research in transepidermal drug 
delivery. In particular, ultrafine nanoparticles ranging from 
1 to 100 nm can be utilized to encapsulate drug molecules 
and enhance penetration. Some common nanoparticles 
include carbon nanotubes, fullerenes, quantum dots, metals 
(Ag, Au), metal oxides (TiO2, ZnO, Fe2O3, SiO2), and lipo-
philic nanoparticles (Delouise, 2012). The size, shape, rigid-
ity, hydrophobicity, and charge of these nanoparticles can 
be exploited to optimize drug delivery (i.e., to protect labile 
drugs, control release of drugs, and target drug delivery). 
However, adverse effects may exist with the use of nanopar-
ticles because they tend to eventually accumulate in periph-
eral tissue, causing inflammation and damage, no matter 
their inherent size or chemical properties (Minchin, 2008).
CONCLUSION
As high-volume prescribers of topical drugs, dermatolo-
gists should be aware of the factors that influence topical 
drug efficacy and safety. Specifically, it is important to know 
what effects varying individual parameters (i.e., excipients, 
vehicles, etc.) can have on enhancing drug penetration 
into the epidermis. When presented with a topical drug, a 
dermatologist can then appropriately decide a drug’s true 
capabilities versus the claims made about the drug. In Part 
2 of this Research Techniques Made Simple, we will discuss 
the techniques used to objectively assess topical bioavail-
ability, giving the reader an even better appreciation of tran-
sepidermal drug delivery.
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